Literature DB >> 16242912

Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.

Kalliopi Zachou1, Eirini I Rigopoulou, Aikaterini Tsikrikoni, Michael G Alexandrakis, Freda Passam, Despina S Kyriakou, Nicolaos E Stathakis, Georgios N Dalekos.   

Abstract

We have recently reported differences in the hematopoiesis between autoimmune hepatitis type 1 (AIH-1) and primary biliary cirrhosis (PBC). In view of the notion that cytokines are regulators of hematopoiesis, we investigated in our tertiary center the cytokine production in the bone marrow (BM) of the same consecutive cohort of patients (13 AIH-1, 13 PBC, 10 healthy and 7 patients with cirrhosis due to chronic hepatitis B). Interferon-gamma (IFN-gamma), interleukin-4 (IL-4), interleukin-10 (IL-10), tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) were determined in the supernatants of long-term BM cultures by ELISAs. IL-4, TNF-alpha and TGF-beta were found significantly increased in the BM of PBC patients compared to AIH-1 and both control groups. AIH-1 patients had significantly higher BM IL-10 compared to PBC patients and higher IL-10, IL-4 and TNF-alpha compared to controls. BM IFN-gamma was significantly higher in PBC and AIH-1 patients compared to controls. In AIH-1 patients, IL-10 was positively correlated with CD34+, CD34+/CD38- and CD34+/CD38+ cell proportions. In conclusion, the BM cytokine microenvironment of PBC and AIH-1 patients differs significantly compared to that of healthy individuals and cirrhotic patients of non-autoimmune etiology. Differences were also found between patients with PBC and AH-1. The implication of BM in the pathogenesis of autoimmune liver diseases is possible and needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242912     DOI: 10.1016/j.jaut.2005.08.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis.

Authors:  Dandan Wang; Huayong Zhang; Jun Liang; Zhifeng Gu; Qiang Zhou; Xiangshan Fan; Yayi Hou; Lingyun Sun
Journal:  Cell Mol Immunol       Date:  2010-08-23       Impact factor: 11.530

2.  Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.

Authors:  Guo-Xiang Yang; Zhe-Xiong Lian; Ya-Hui Chuang; Yuki Moritoki; Ruth Y Lan; Kanji Wakabayashi; Aftab A Ansari; Richard A Flavell; William M Ridgway; Ross L Coppel; Koichi Tsuneyama; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

3.  CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease.

Authors:  Guo-Xiang Yang; Yuehong Wu; Hiroki Tsukamoto; Patrick S Leung; Zhe-Xiong Lian; Daniel B Rainbow; Kara M Hunter; Gerard A Morris; Paul A Lyons; Laurence B Peterson; Linda S Wicker; M Eric Gershwin; William M Ridgway
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

4.  Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis.

Authors:  Motoko Sasaki; Hiroko Ikeda; Seiko Sawada; Yasunori Sato; Yasuni Nakanuma
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

5.  Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.

Authors:  Theodoros A Zografos; Nikolaos Gatselis; Kalliopi Zachou; Christos Liaskos; Stella Gabeta; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2012-09-14       Impact factor: 5.742

6.  IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.

Authors:  Stella Gabeta; Gary L Norman; Nikolaos Gatselis; Christos Liaskos; Panagiotis A Papamichalis; Athanasios Garagounis; Kalliopi Zachou; Eirini I Rigopoulou; George N Dalekos
Journal:  J Clin Immunol       Date:  2008-06-13       Impact factor: 8.317

7.  ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.

Authors:  Shi-Ying Cai; Samir Gautam; Trong Nguyen; Carol J Soroka; Christoph Rahner; James L Boyer
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

8.  The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms.

Authors:  Khanh Vinh Quốc L Ng; Lan Thi Hoàng Nguyễn
Journal:  Gastroenterol Res Pract       Date:  2013-03-26       Impact factor: 2.260

9.  Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  Stella Gabeta; Gary L Norman; Christos Liaskos; Panagiotis A Papamichalis; Theodoros Zografos; Athanasios Garagounis; Eirini I Rigopoulou; George N Dalekos
Journal:  J Clin Immunol       Date:  2007-05-21       Impact factor: 8.542

10.  APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.

Authors:  Hong You; Xiong Ma; Cumali Efe; Guiqiang Wang; Sook-Hyang Jeong; Kazumichi Abe; Weijia Duan; Sha Chen; Yuanyuan Kong; Dong Zhang; Lai Wei; Fu-Sheng Wang; Han-Chieh Lin; Jin Mo Yang; Tawesak Tanwandee; Rino A Gani; Diana A Payawal; Barjesh C Sharma; Jinlin Hou; Osamu Yokosuka; A Kadir Dokmeci; Darrell Crawford; Jia-Horng Kao; Teerha Piratvisuth; Dong Jin Suh; Laurentius A Lesmana; Jose Sollano; George Lau; Shiv K Sarin; Masao Omata; Atsushi Tanaka; Jidong Jia
Journal:  Hepatol Int       Date:  2022-02-04       Impact factor: 6.047

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.